Venous Stenosis
0
Pipeline Programs
1
Companies
5
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Merit MedicalSOUTH JORDAN, UT
5 programsMerit WRAPSODY Endovascular Stent GraftN/A1 trial
Merit WRAPSODY Endovascular Stent GraftN/A1 trial
Merit WRAPSODY Endovascular Stent GraftN/A1 trial
Merit WRAPSODY® Cell Impermeable EndoprosthesisN/A1 trial
WRAPSODY Stent Graft PlacementN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Merit MedicalMerit WRAPSODY® Cell Impermeable Endoprosthesis
Merit MedicalMerit WRAPSODY Endovascular Stent Graft
Merit MedicalMerit WRAPSODY Endovascular Stent Graft
Merit MedicalMerit WRAPSODY Endovascular Stent Graft
Merit MedicalWRAPSODY Stent Graft Placement
Clinical Trials (5)
Total enrollment: 1,153 patients across 5 trials
WRAP North America
Start: Jul 2025Est. completion: Jul 2030250 patients
N/ARecruiting
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
Start: Jun 2022Est. completion: Oct 2027500 patients
N/AActive Not Recruiting
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
Start: Mar 2021Est. completion: Jan 2026357 patients
N/AActive Not Recruiting
The Merit WRAPSODY Central Feasibility Study
Start: Mar 2021Est. completion: Feb 20240
N/AWithdrawn
The Merit WRAPSODY™ Endovascular Stent Graft
Start: Jan 2019Est. completion: Jan 202146 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,153 patients
1 companies competing in this space